Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1 1

Status

Completed 3

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3Thoracic 1Gastrointestinal 1

Conditions

Colorectal Neoplasms 70Neoplasm Metastasis 20Rectal Neoplasms 19Colonic Neoplasms 17Neoplasms 11Cholangiocarcinoma 7Carcinoma, Non-Small-Cell Lung 7Head and Neck Neoplasms 6Esophageal Neoplasms 6Breast Neoplasms 6Carcinoma, Squamous Cell 5Triple Negative Breast Neoplasms 4Pancreatic Neoplasms 4Ovarian Neoplasms 4Lung Neoplasms 4Colorectal Cancer Metastatic 4Squamous Cell Carcinoma of Head and Neck 3Recurrence 3Prostatic Neoplasms 3Inflammatory Breast Neoplasms 3Carcinoma 3Adenocarcinoma Of Esophagus 3Adenocarcinoma 3Urinary Bladder Neoplasms 2Stomach Neoplasms 2Fallopian Tube Neoplasms 2Biliary Tract Neoplasms 2Uterine Cervical Neoplasms 1Serotonin Syndrome 1Salivary Gland Malignancy 1

Interventions

Docetaxel 137Prednisone 120Abiraterone Acetate 91Leuprolide 86enzalutamide 84Radiotherapy 59bicalutamide 56Magnetic Resonance Spectroscopy 54Goserelin 54Androgen Antagonists 51acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 47apalutamide 44abiraterone 34Radiosurgery 31Specimen Handling 30gallium 68 PSMA-11 29Gonadotropin-Releasing Hormone 29cabazitaxel 28Carboplatin 27darolutamide 25Estramustine 24luprolide acetate gel depot 23relugolix 22Metformin 22Triptorelin Pamoate 20sipuleucel-T 19radium Ra 223 dichloride 19Radiation 19pembrolizumab 18deltacortene 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Prostatic Neoplasms × Panitumumab × Clear all
NCT00054574 2020-08-03

Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer

Jonsson Comprehensive Cancer Center

Phase 2 Completed
Genitourinary

Prostatic Neoplasms

NCT00425204 2008-09-15

Study for Patients Who Have Benefited and Tolerated Prior Panitumumab Treatment

Amgen

Phase 2 Completed
31 enrolled
GastrointestinalGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Prostatic Neoplasms, Colorectal Neoplasms

NCT00061126 2005-06-24

ABX-EGF (a Monoclonal Antibody) Given to Patients With Prostate Cancer With or Without Tumor in Other Parts of the Body

Abgenix

Phase 2 Completed
50 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡